Mallinckrodt Pharmaceuticals
MNK
$0.34
Share price
0.00%
Change (1 day)
-93.81%
Change (1 year)
Categories
Mallinckrodt Pharmaceuticals (MNK) - Total debt
Total debt on the balance sheet as of June 2023 : $3.09 B
According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's total debt is $3.09 B. A company’s total debt is the sum of all current and non-current debts.
Mallinckrodt Pharmaceuticals - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $3.07 B | 121.17% |
| 2021-12-31 | $1.38 B | -61.29% |
| 2020-12-31 | $3.58 B | -33.25% |
| 2019-12-31 | $5.37 B | -11.77% |
| 2018-12-31 | $6.09 B | -9.55% |
| 2017-12-31 | $6.73 B | |
| 2016-09-30 | $6.04 B | -6.95% |
| 2015-09-30 | $6.49 B | 63.53% |
| 2014-09-30 | $3.97 B | 331.91% |
| 2013-09-30 | $0.91 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 846.62% | 🇺🇸 USA |
 General Electric GE | $20.52 B | 562.40% | 🇺🇸 USA |
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $20.15 B | 550.39% | 🇮🇱 Israel |